qPCR data reveals that ULK1 mRNA expression decreased in CBZ treated KRAS-mut CRC at both 6 and 24 h, with a fold change of 0.50 and 0.60 (p < 0.01 and p < 0.001 respectively) and was not changed in KRAS-wt CRC. This evidence concerns the gene KRAS and colorectal carcinoma.